The Role of Analytics in Strategic Decision-Making for Pharma and Biotech

Sponsored content for Doctor Evidence by studioID

Duration: 1 hour

Today’s pharma and biotech professionals are challenged with making sense of the overwhelming volume of clinical trial and RWE data used to develop products in order to meet accelerated commercial demands. However, the ability to generate robust, actionable data insights quickly and confidently is often beyond even the most experienced team’s scope.

Doctor Evidence and studioID invite you to hear from accomplished senior experts in the industry, publishing and academia as they debate the important questions facing biopharma today and reveal solutions to help you accelerate key decision-making processes and improve clinical and commercial performance. The panel discussion will include:

  • Industry changes and challenges of the last few years
  • Technology’s role in the conduct of literature reviews and analytics
  • The appropriate roles of systematic reviews and rapid reviews
  • Technology and analytics solutions that can help advance product development and lifecycle management


Athula Herath, PhD, MBCS, CEng
Founder, Hospite Foundation
Former Global Head, RWE Epidemiology, Novartis Pharmaceuticals

David Tovey, MB.ChB., FRCGP
Co-Editor in Chief
Journal of Clinical Epidemiology

Craig Whittington, PhD FIScT
Group Director Literature Synthesis & Biostatistics, Real World Evidence Generation
Sanofi Digital

Evangelia Ntzani, MD, PhD
Associate Professor of Epidemiology, Head in Department of Hygiene and Epidemiology
University of Ioannina, School of Medicine


Toby Sayre, MS
Chief Commercial Officer
Doctor Evidence


Field will not be visible to web visitor
Field will not be visible to web visitor
Field will not be visible to web visitor
Field will not be visible to web visitor
Field will not be visible to web visitor

Copyright 2020 Industry Dive | Privacy Policy | Terms of Use